منابع مشابه
Vigabatrin dosing during haemodialysis
The antiepileptic drug vigabatrin has shown efficacy in the treatment of patients with refractory epilepsy. Unlike many other antiepileptics it is not bound to plasma protein and mainly eliminated by the kidney. Although the therapeutic and toxic serum concentration range is not clearly defined and efficacy and toxicity are not closely correlated with the dose, factors decreasing vigabatrin eli...
متن کاملPharmacokinetics of the S(+) and R(-) enantiomers of vigabatrin during chronic dosing in a patient with renal failure.
AIMS To study the pharmacokinetics of vigabatrin in a patient affected with tuberous sclerosis who developed major agitation and aggression, while receiving vigabatrin orally (1.5 g every 12 h) and in whom impaired renal function was diagnosed. METHODS The patient received vigabatrin (0.5 g day(-1)). A pharmacokinetic study of the S(+) and R(-) enantiomers of vigabatrin was performed before a...
متن کاملComplications During Haemodialysis
Aim: To determine the frequency of different complications during haemodialysis. Methods: This prospective study was conducted at Nephrology section of Nishtar Hospital, Multan from July 2012 to January 2013. A total of 227 patients were included in the study. Results: The most frequently observed complications were depressive illness, vomiting, fever, itching and hypotension. The causative rel...
متن کاملPsoriatic clearance during haemodialysis.
He came under the care of one of us (J.McE.), at the Nephrology Clinic some years ago because of chronic renal failure on a basis of chronic -pyelonephritis. This was managed conservatively with the usual fluid and dietary restrictions, but the condition progressed and eventually became terminal in August, 1973. At that stage he was admitted with a view to assessment for the chronic dialysis/tr...
متن کاملAcute pancreatitis during haemodialysis
mechanism behind this apparent thalidomide-induced hyperkalaemia remains unclear. Therefore, the authors recommend caution when thalidomide is used in patients with moderate to severe renal failure (serum creatinine >300mmol/l) or in patients on dialysis. To go a step further, we think that thalidomide should in all cases be started at a dosage that should not exceed 100mg/day. It is also impor...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Seizure
سال: 1996
ISSN: 1059-1311
DOI: 10.1016/s1059-1311(96)80043-4